Data protection Impressum

Financing

Biotech KYLYS Aesthetics has raised CHF 1 million to advance clinical development of its next-generation hyaluronic acid medical devices for regenerative aesthetic medicine.

Geneva-based KYLYS raises CHF 1 million to advance regenerative aesthetic medicine

23 June 2025

With continued leadership in government efficiency and infrastructure, Switzerland has been named the world’s most competitive economy in the 2025 edition of the IMD World Competitiveness Ranking.

Switzerland tops IMD’s 2025 World Competitiveness Ranking

17 June 2025

Start-ups Aseptuva, Bloom Biorenewables, and Hafnova have been selected for multi-year EU-funded projects, reinforcing Western Switzerland’s importance in health tech, sustainable chemistry and cybersecurity.

Three rising Western Switzerland start-ups join major European innovation programs

3 June 2025

Hedera Dx has secured EUR 15 million to expand hospital-based cancer diagnostics, making precision oncology more accessible to patients worldwide.

Hedera Dx raises EUR 15 million to expand access to precision cancer care

27 May 2025

Geneva-based Syrhatech has raised CHF 4.5 million to expand its R&D and manufacturing of injectable hyaluronic acid-based medical devices to support growing demand in dermatology, orthopedics, and ophthalmology.

Syrhatech raises CHF 4.5 million to innovate in hyaluronic acid medical devices

27 May 2025

Lausanne-based biotech ReproNovo has secured USD 65 million to advance Phase 2 trials for novel therapies in male infertility and women’s reproductive health.

ReproNovo raises USD 65 million to advance trials in reproductive health

21 May 2025

Colb Asset SA, a Geneva-based fintech company specializing in real-world asset tokenization, has secured CHF 6 million in an oversubscribed seed extension round. The funding aims to broaden access to traditionally exclusive investment opportunities through blockchain technology.

Geneva-based Colb raises CHF 6 million to tokenize pre-IPO investments on blockchain

13 May 2025

DemoSquare has successfully raised CHF 1.2 million in pre-seed funding to fuel its expansion into European markets, aiming to enhance its AI-based platform for monitoring political and regulatory activities.

DemoSquare launches EU platform in Brussels to expand AI-based policy monitoring

13 May 2025

The Lausanne Region Trophy at the 23rd Prix Entreprendre Lausanne Région (PERL) ceremony has been awarded to Carewell, a Pully-based start-up optimizing healthcare staffing through a digital platform that merges technological and social innovation.

Carewell wins 2025 PERL Award for innovation in healthcare staffing

12 May 2025

HAYA Therapeutics, a precision medicine company based at Biopôle in Lausanne, has closed a USD 65 million Series A funding round to accelerate the clinical development of its RNA-guided therapies and expand its regulatory genome platform.

HAYA Therapeutics raises USD 65 million to advance RNA-guided therapies for chronic disease

12 May 2025

1 2 3 4 5 6 7 8 9 10 … 37